Genomtec Cash Flow Statement

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-9.01	-11.93	-7.12	-10.94
Depreciation & Amortization	1.16	0.44	0.5	0.24
Loss (Gain) From Sale of Assets	-0.08	-	-	-
Other Operating Activities	0.05	5.09	0.25	9.06
Change in Accounts Receivable	-1.29	-0.08	-0.06	-0.14
Change in Inventory	0.11	0.09	-0.08	-0.11
Change in Unearned Revenue	1	2.53	0.46	-0.07
Change in Other Net Operating Assets	0.12	0.27	0.54	-0.54
Operating Cash Flow	-7.95	-3.6	-5.5	-2.5
Capital Expenditures	-3.53	-4.33	-0.21	-0.13
Sale of Property, Plant & Equipment	0.11	-	-	-
Other Investing Activities	0.06	-	-	0
Investing Cash Flow	-3.8	-4.33	-0.21	-0.08
Short-Term Debt Issued	-	-	0.3	0.35
Long-Term Debt Issued	0.5	10.32	-	-
Total Debt Issued	0.5	10.32	0.3	0.35
Short-Term Debt Repaid	-	-	-0.25	-0.1
Long-Term Debt Repaid	-1.03	-10.64	-0.25	-0.15
Total Debt Repaid	-1.03	-10.64	-0.5	-0.25
Net Debt Issued (Repaid)	-0.53	-0.32	-0.2	0.1
Issuance of Common Stock	12.43	11.2	-	8.37
Other Financing Activities	-0.1	-0.19	-0.03	-0.02
Financing Cash Flow	11.8	10.7	-0.22	8.45
Net Cash Flow	0.04	2.77	-5.94	5.87
Free Cash Flow	-11.48	-7.93	-5.71	-2.63
Free Cash Flow Margin	-1147900.00%	-19822.50%	-2608.68%	-13135.00%
Free Cash Flow Per Share	-0.94	-0.85	-0.70	-0.32
Cash Interest Paid	0.1	0.19	0.03	0.02
Levered Free Cash Flow	-5.45	-11.46	-3.12	-
Unlevered Free Cash Flow	-5.45	-11.34	-3.11	-
Change in Working Capital	-0.06	2.81	0.86	-0.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.